Nearly one out of every 20 staff in the FDA offices that oversee drugs and biologics are gone after the Trump administration ...

President Donald Trump unofficially asked CMS Administrator Mehmet Oz to lead the administration’s talks with drugmakers to ...

The US Customs and Border Protection warns drugmakers against misrepresenting product values to evade import rules ahead of ...

Plus, news about Sanofi, Servier, BioNova, Arcutis, Roche, Satellos Bioscience, Fore Biotherapeutics, Cinclus Pharma and Zentiva.

The Trump administration has been barred from carrying out its sweeping plan to restructure and downsize the Department of ...

Geoffrey Porges, a longtime biotech analyst and well-known Wall Street figure, stepped down as CFO of the New York biotech ...

Volastra reports promising Phase 1/2 data for VLS-1488 in solid tumors, with good safety and early efficacy signals in ...

After a median 34.2 months of follow-up, patients taking Itovebi in combination with Pfizer’s Ibrance and AstraZeneca’s Faslodex survived for a median of 34 months, compared to 27 months for those ...

The White House released its first MAHA Commission report, detailing some of the Trump administration’s top priorities for ...

The House of Representatives on Thursday passed President Donald Trump’s tax cut package, with steep Medicaid cuts, PBM ...

FDA Commissioner Marty Makary defended thousands of staff cuts during his first congressional hearing since taking office, ...

FDA names Elizabeth Miller as acting associate commissioner of OII; J&J's Wolk emphasizes tax reform for US manufacturing; ...